BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6865893)

  • 1. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
    Noguchi CT; Ackerman S; DiMaio J; Schiller PW; Schechter AN
    Mol Pharmacol; 1983 Jan; 23(1):100-3. PubMed ID: 6865893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptides as inhibitors of the gelation of sickle hemoglobin.
    Noguchi CT; Luskey KL; Pavone V
    Mol Pharmacol; 1985 Jul; 28(1):40-4. PubMed ID: 4021996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regioselective covalent modification of hemoglobin in search of antisickling agents.
    Park S; Hayes BL; Marankan F; Mulhearn DC; Wanna L; Mesecar AD; Santarsiero BD; Johnson ME; Venton DL
    J Med Chem; 2003 Mar; 46(6):936-53. PubMed ID: 12620071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of sickle hemoglobin gelation by amino acids and related compounds.
    Noguchi CT; Schechter AN
    Biochemistry; 1978 Dec; 17(25):5455-9. PubMed ID: 728408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
    Safo MK; Abdulmalik O; Danso-Danquah R; Burnett JC; Nokuri S; Joshi GS; Musayev FN; Asakura T; Abraham DJ
    J Med Chem; 2004 Sep; 47(19):4665-76. PubMed ID: 15341482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 2-imidazolines as anti-sickling agents.
    Chang H; Ewert SM; Nagel RL
    Mol Pharmacol; 1983 May; 23(3):731-4. PubMed ID: 6865916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and testing of potential antisickling agents. 6. Rheologic studies with active phenoxy and benzyloxy acids.
    Patwa DC; Abraham DJ; Hung TC
    Blood Cells; 1987; 12(3):589-601. PubMed ID: 3651614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereospecific inhibitors of the gelation of sickle hemoglobin.
    Schechter AN
    Hemoglobin; 1980; 4(3-4):335-45. PubMed ID: 7419427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton NMR studies of the molecular basis for the anti-sickling activity of non-covalent antisickling compounds.
    Ho C; Russu IM
    Prog Clin Biol Res; 1987; 240():59-66. PubMed ID: 3615505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease.
    Pagare PP; Ghatge MS; Musayev FN; Deshpande TM; Chen Q; Braxton C; Kim S; Venitz J; Zhang Y; Abdulmalik O; Safo MK
    Bioorg Med Chem; 2018 May; 26(9):2530-2538. PubMed ID: 29655608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of a spin-labeled phenylalanine analog to sickle hemoglobin: EPR and NMR studies.
    Lu HZ; Currie BL; Johnson ME
    FEBS Lett; 1984 Jul; 173(1):259-63. PubMed ID: 6086399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle hemoglobin aggregation: a new class of inhibitors.
    Votano JR; Gorecki M; Rich A
    Science; 1977 Jun; 196(4295):1216-9. PubMed ID: 870976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of shear on the delay time for gelation of hemoglobin S.
    Briehl RW
    Blood Cells; 1982; 8(2):201-12. PubMed ID: 7159745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisickling activity of amino acid benzyl esters.
    Gorecki M; Acquaye CT; Wilchek M; Votano JR; Rich A
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):181-5. PubMed ID: 6928612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
    Berkowitz LR; Orringer EP
    Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease.
    Votano JR; Altman J; Wilchek M; Gorecki M; Rich A
    Proc Natl Acad Sci U S A; 1984 May; 81(10):3190-4. PubMed ID: 6587344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of fifteen anti-sickling agents.
    Chang H; Ewert SM; Bookchin RM; Nagel RL
    Blood; 1983 Apr; 61(4):693-704. PubMed ID: 6338971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin.
    Abdulmalik O; Ghatge MS; Musayev FN; Parikh A; Chen Q; Yang J; Nnamani I; Danso-Danquah R; Eseonu DN; Asakura T; Abraham DJ; Venitz J; Safo MK
    Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):920-8. PubMed ID: 22101818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of pyridine derivatives of L-phenylalanine as antisickling reagents.
    Altman J; Gorecki M; Wilchek M; Votano JR; Rich A
    J Med Chem; 1984 May; 27(5):596-600. PubMed ID: 6716398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.